ZHX2 and lipoprotein glomerulopathy: Adriamycin injection studies in 3 lines of podocyte-specific Zhx2-overexpressing transgenic rats show development of collapsing glomerulopathy beyond a certain threshold of Zhx2 overexpression (27).